Epoxyeicosanoid signaling in CNS function and disease - Test2 - elhamkhani - TriplyDB

Epoxyeicosanoid signaling in CNS function and disease

Epoxyeicosanoid signaling in CNS function and disease

http://www.wikidata.org/entity/Q28394441

about

Sex differences in stroke: the contribution of coagulation Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling Soluble Epoxide Hydrolase in Hydrocephalus, Cerebral Edema, and Vascular Inflammation After Subarachnoid Hemorrhage Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke Possible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders Development of an HTS assay for EPHX2 phosphatase activity and screening of nontargeted libraries Cytochrome P450 eicosanoids and cerebral vascular function Mechanism of protection by soluble epoxide hydrolase inhibition in type 2 diabetic stroke The neurovascular unit in brain function and disease.Cytochrome P450 2C24: Expression, Tissue Distribution, High-Throughput Assay, and Pharmacological Inhibition.Role of soluble epoxide hydrolase phosphatase activity in the metabolism of lysophosphatidic acids.Role of soluble epoxide hydrolase in age-related vascular cognitive decline.Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesic.Soluble epoxide hydrolase as an anti-inflammatory target of the thrombolytic stroke drug SMTP-7 Epoxyeicosatrienoic acids enhance axonal growth in primary sensory and cortical neuronal cell cultures.Soluble epoxide hydrolase gene deletion improves blood flow and reduces infarct size after cerebral ischemia in reproductively senescent female mice.Epoxy fatty acids and inhibition of the soluble epoxide hydrolase selectively modulate GABA mediated neurotransmission to delay onset of seizures.Effects of acetylenic epoxygenase inhibitors on recombinant cytochrome p450s Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in brain of HIV-1 transgenic rats Differential effect of amyloid β on the cytochrome P450 epoxygenase activity in rat brain Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain Opioid Analgesia in P450 Gene Cluster Knockout Mice: A Search for Analgesia-Relevant Isoforms Vascular pharmacology of epoxyeicosatrienoic acids Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes.Soluble epoxide hydrolase: sex differences and role in endothelial cell survival.Soluble epoxide hydrolase inhibitor enhances synaptic neurotransmission and plasticity in mouse prefrontal cortex.Protective role of p450 epoxyeicosanoids in subarachnoid hemorrhage.Cytochrome P450 subfamily 2J polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia.Aging is associated with altered inflammatory, arachidonic acid cascade, and synaptic markers, influenced by epigenetic modifications, in the human frontal cortex.Plasma oxylipin profiling identifies polyunsaturated vicinal diols as responsive to arachidonic acid and docosahexaenoic acid intake in growing piglets.Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer's disease.Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus.Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke.The protective effect of astrocyte-derived 14,15-epoxyeicosatrienoic acid on hydrogen peroxide-induced cell injury in astrocyte-dopaminergic neuronal cell line co-culture.Lipidomics of polyunsaturated-fatty-acid-derived oxygenated metabolites.Modulation of T-type calcium channels by bioactive lipids.Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation.P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection.14,15-epoxyeicosatrienoic acid promotes production of brain derived neurotrophic factor from astrocytes and exerts neuroprotective effects during ischaemic injury.

P2860

Q27022768-392ED0FD-7910-463B-AD13-AF3F810B4B05 Q28245279-EFF57E02-0532-4481-8E0C-22619630C2E7 Q28248377-52DF5F52-3F3F-4F9C-AB18-7BD8132F83BD Q28262216-85671B6B-6183-479D-B527-822E033E9F66 Q28271874-F790DB82-3BBD-476C-96C2-61F7B92CD638 Q28386662-9415AA8C-1D3C-44DB-A99A-B875B63752C5 Q28393751-F51F9414-580D-4B2D-8ED2-FBB0802DEA71 Q28396302-F1170E88-42A4-46BE-B59F-7BE6C7155E9F Q33604701-A27825CD-0308-4C15-98CB-31BA04B7A4F4 Q33805295-7927629F-FC24-42D8-B03E-0CA1D6C575AA Q33939653-92F6E4AD-8EE9-43AD-8E62-AFDC58F60008 Q34183871-1992F671-973D-4352-87FF-E1809DAA55FA Q34622501-48A73045-DDDC-4C77-9C20-405D2603B29A Q34728973-F4944FD5-3F84-4299-8D93-D8E4630B46B2 Q34774458-76806F9D-B8E5-463A-AA76-6877CBDD8F32 Q34842312-645C9962-B37B-48EC-A741-E2CF9D2C117B Q34969971-EAB8BB06-7080-45AC-B9D7-4407AA3D6013 Q35069446-0417E2B6-7FD1-4D57-BBE7-147A5E4F2054 Q35079537-74CA535B-475C-4907-AFEA-C391F4C15E2F Q35218599-0C040061-86CF-4B29-8099-B35CDF9FF37B Q35243119-083C08CA-DD2F-4FB4-B639-D49C8E9CA371 Q35844193-E1CD181B-63D6-41A7-945D-1EA900B6B35D Q35962010-7B6F4E73-81DB-49D8-8FB9-ECFC2F849B58 Q36027183-579A6EEF-B694-4814-B961-079D0D59ED23 Q36094369-696AB23F-BAC8-4254-840E-5F9FD3450BAD Q36160027-5AD1CCA8-F820-4882-8903-2EF26936A137 Q36202208-42F2EC0D-140A-495F-A605-0A2A1E230860 Q36483681-20D4EBCC-1D29-464A-98A9-1F75A78E05C9 Q36528411-1C5CF92E-C328-4104-97B2-CBCC8A4D81A0 Q36711420-9D1F89F9-8F3A-4634-830B-6BC78F3582EC Q36822568-775B8B4B-7C06-4C0D-939C-CD541DBB8CEA Q36888838-6C2FA051-6F25-4DDB-B0A4-34502758B1F7 Q37216148-E935BA54-208A-4D97-8141-472DD70EA05A Q37440238-CB1E1386-A97D-4122-9C21-1D79A41A3B5E Q37730277-5C9AF01C-2C6C-4707-98D0-4B2F4993454B Q37936503-4EA80931-71FF-4519-91DF-3F3B3FE4BD75 Q38188442-A0A3882F-8126-4F1F-880F-AD1BD68E372E Q38736745-022A2605-883D-46F3-900C-6F278EE16FAA Q38744600-4F1AB658-67D0-4D90-BFC3-045FC6B4D6BD Q38822739-2EF334C8-CFD3-4787-AC7D-6275EDB80953

P2860

Epoxyeicosanoid signaling in CNS function and disease

http://www.wikidata.org/entity/Q28394441

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Epoxyeicosanoid signaling in CNS function and disease

@ast

Epoxyeicosanoid signaling in CNS function and disease

@en

Epoxyeicosanoid signaling in CNS function and disease

@nl

type

label

Epoxyeicosanoid signaling in CNS function and disease

@ast

Epoxyeicosanoid signaling in CNS function and disease

@en

Epoxyeicosanoid signaling in CNS function and disease

@nl

prefLabel

Epoxyeicosanoid signaling in CNS function and disease

@ast

Epoxyeicosanoid signaling in CNS function and disease

@en

Epoxyeicosanoid signaling in CNS function and disease

@nl

P1433

Q28394441-1B75C0E3-6DF7-41E8-9F01-CF24CC6B469C

P1476

Q28394441-1F81F4F7-3055-48A4-ADE6-A07D8661FBE0

P2093

Q28394441-272C29BA-FB05-4A4D-80B9-C8EB58FEA443

Q28394441-2755028A-F6D5-4068-9B86-2DAAF6837762

Q28394441-54CD3589-EA96-42CA-8A1F-E3F19671DB7E

Q28394441-62DC1AD6-F4FE-4B5B-99D6-39ED5AEF6A01

Q28394441-77C9931A-D6D9-461C-89DF-016AC2CB3043

Q28394441-7CBFB460-04AC-4DDC-96C0-BC2B1B197394

P2860

Q28394441-011EFF91-E697-4783-BBF9-0BCB05FEC214

Q28394441-01E8AAB6-17C7-405D-8A8A-E59086062D9F

Q28394441-035BB4B7-7758-4A35-8FE5-4EAFD8B9165C

Q28394441-03E6AC96-31ED-4654-81A0-5566A38C2D80

Q28394441-04405232-D0B5-491A-A278-E254042B9401

Q28394441-069D0165-5182-4A3D-A1EB-2570908C5CCF

Q28394441-08315502-79C5-4CF3-8CBE-57570FE258FE

Q28394441-09984DC5-E21A-48B6-A7FA-A36FF55E4911

Q28394441-0AFB96AF-A403-4BD3-8B8B-40C8540142D4

Q28394441-0B0B3606-61CA-46C8-BC14-4813A7EBBC67

P304

Q28394441-D1FA83EA-3742-4F0C-98F9-1FE98C2AF997

P31

Q28394441-5582028A-7FE3-444F-8288-C2CBC1AD0A0B

P356

Q28394441-7DE7C014-5252-4E30-8E33-885DBCFCBC45

P407

Q28394441-4E0BEF6F-2851-464D-A3C2-06EE4847D503

P433

Q28394441-96868EC8-D07A-4C60-AB55-A9140E11F02F

P478

Q28394441-8E35B00B-F804-4C7D-A3EA-DF42DDFFBE7C

P577

Q28394441-21FD5D64-07CD-4EA2-94EC-003769843A5F

P5875

Q28394441-97C91CB0-CF60-44A0-891B-C252A28F8940

P698

Q28394441-05FC357A-ABE6-4659-8A6C-0B15231B77CB

P921

Q28394441-900501EE-B464-4164-BC04-7F687BEBA427

P932

Q28394441-9005C7F1-D7AB-445F-A48E-EBE2A67C8581

P356

J.PROSTAGLANDINS.2009.06.004

P1433

Prostaglandins and Other Lipid Mediators

P1476

Epoxyeicosanoid signaling in CNS function and disease

@en

P2093

Jeffrey J Iliff

http://www.w3.org/2001/XMLSchema#string

Jia Jia

http://www.w3.org/2001/XMLSchema#string

Jonathan Nelson

http://www.w3.org/2001/XMLSchema#string

Judy Klaus

http://www.w3.org/2001/XMLSchema#string

Nabil J Alkayed

http://www.w3.org/2001/XMLSchema#string

Toru Goyagi

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study

Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2

Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis

Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function

Epoxide hydrolases: their roles and interactions with lipid metabolism

Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors

Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway

Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

Cytochrome P450 2C is an EDHF synthase in coronary arteries

P304

68-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PROSTAGLANDINS.2009.06.004

http://www.w3.org/2001/XMLSchema#string

P407

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26310233

http://www.w3.org/2001/XMLSchema#string

P698

19545642

http://www.w3.org/2001/XMLSchema#string

P921

P932

2844927

http://www.w3.org/2001/XMLSchema#string